Beaverton residents who purchased generic prescriptions for common drugs like albuterol, amitriptyline, or amphetamine/dextroamphetamine between 2009 and 2019 could have money coming back to them.
Oregon Attorney General Dan Rayfield announced July 15 that generic drug manufacturer Glenmark Pharmaceuticals will pay $29.6 million to settle federal antitrust allegations that it conspired with other companies to inflate prescription drug prices. Oregon's share of the settlement is $316,000.
"Glenmark was working with other drug companies to keep prices artificially high, and Oregon families paid for it every time they picked up a prescription," Rayfield said in a statement. "This is money out of people's pockets for medications they needed."
Who qualifies
Oregon residents, including those in Beaverton, who purchased generic prescription drugs manufactured by Glenmark, Lannett, Bausch Health, Apotex, or Heritage Pharmaceuticals between May 1, 2009, and December 31, 2019, may be eligible for a payout.
The drugs must have been purchased in the United States and not for resale.
The list of qualifying medications includes treatments for asthma, depression, anxiety, ADHD, gout, acne, glaucoma, and epilepsy, among others. The full drug list is posted at AGGenericDrugs.com and was last updated May 19, 2025.
Of the $29.6 million total, $20.7 million is set aside for consumer distribution through a restitution fund. The remaining $8.9 million covers administration costs and reimburses state attorneys general for litigation expenses, according to the settlement website.
How to file
The claims process has not yet opened. Consumers cannot file a claim form yet but can register at AGGenericDrugs.com or call 1-866-290-0182 to be notified when it becomes available. The site is available in seven languages, including Spanish, Chinese, and Vietnamese.
Those who previously registered for earlier settlements in the same case do not need to register again.
Deadlines for opting out or objecting have not been set.
The bigger picture
Glenmark is the fifth pharmaceutical company to settle with Oregon and dozens of other state attorneys general over generic drug price-fixing in the past decade. Four prior companies settled for a combined total of nearly $67 million, according to the Beaverton Valley Times.
The multistate lawsuits, originally filed in U.S. District Court in Connecticut, were built on investigations involving more than 20 million documents, phone records, and interviews with industry witnesses.
Evidence in the case showed executives from competing companies met at parties, golf outings, and social gatherings to make illegal agreements to keep prices high.
Former Oregon Attorney General Ellen Rosenblum joined three major multistate antitrust lawsuits against Glenmark and other pharmaceutical companies between 2016 and 2020.
One of those suits, filed in 2020, remains in litigation.
As part of its settlement, Glenmark agreed to cooperate in the ongoing cases. The company denies wrongdoing, and the settlement does not question the safety or effectiveness of any of the drugs involved.
Rayfield's office has pursued other drug-pricing cases as well. In 2025, his office secured a $9.25 million settlement from two testosterone replacement gel manufacturers.
In January 2026, Rayfield filed suit against six major pharmaceutical companies and pharmacy benefit managers in Multnomah County Circuit Court over alleged insulin price conspiracy.
Beaverton residents can check the qualifying drug list and register for claim notifications at AGGenericDrugs.com, by calling 1-866-290-0182, or by emailing [email protected].
